Global Nasopharyngeal Cancer Drug Market Professional Survey Report 2019

Table of Contents

Executive Summary

1 Industry Overview of Nasopharyngeal Cancer Drug

• 1.1 Definition of Nasopharyngeal Cancer Drug
• 1.2 Nasopharyngeal Cancer Drug Segment by Type
  • 1.2.1 Global Nasopharyngeal Cancer Drug Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 BGBA-317
  • 1.2.3 CBT-501
  • 1.2.4 Apatinib
  • 1.2.5 APG-1387
  • 1.2.6 ARGX-110
  • 1.2.7 ATA-129
  • 1.2.8 Others
• 1.3 Nasopharyngeal Cancer Drug Segment by Applications
  • 1.3.1 Global Nasopharyngeal Cancer Drug Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Hospital
  • 1.3.3 Clinic
  • 1.3.4 Others
• 1.4 Global Nasopharyngeal Cancer Drug Overall Market
  • 1.4.1 Global Nasopharyngeal Cancer Drug Revenue (2014-2025)
  • 1.4.2 Global Nasopharyngeal Cancer Drug Production (2014-2025)
  • 1.4.3 North America Nasopharyngeal Cancer Drug Status and Prospect (2014-2025)
  • 1.4.4 Europe Nasopharyngeal Cancer Drug Status and Prospect (2014-2025)
  • 1.4.5 China Nasopharyngeal Cancer Drug Status and Prospect (2014-2025)
  • 1.4.6 Japan Nasopharyngeal Cancer Drug Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Nasopharyngeal Cancer Drug Status and Prospect (2014-2025)
  • 1.4.8 India Nasopharyngeal Cancer Drug Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Nasopharyngeal Cancer Drug
• 2.3 Manufacturing Process Analysis of Nasopharyngeal Cancer Drug
• 2.4 Industry Chain Structure of Nasopharyngeal Cancer Drug

3 Development and Manufacturing Plants Analysis of Nasopharyngeal Cancer Drug

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Nasopharyngeal Cancer Drug Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Nasopharyngeal Cancer Drug
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Nasopharyngeal Cancer Drug Production and Capacity Analysis
• 4.2 Nasopharyngeal Cancer Drug Revenue Analysis
• 4.3 Nasopharyngeal Cancer Drug Price Analysis
• 4.4 Market Concentration Degree

5 Nasopharyngeal Cancer Drug Regional Market Analysis

• 5.1 Nasopharyngeal Cancer Drug Production by Regions
  • 5.1.1 Global Nasopharyngeal Cancer Drug Production by Regions
  • 5.1.2 Global Nasopharyngeal Cancer Drug Revenue by Regions
• 5.2 Nasopharyngeal Cancer Drug Consumption by Regions
• 5.3 North America Nasopharyngeal Cancer Drug Market Analysis
  • 5.3.1 North America Nasopharyngeal Cancer Drug Production
  • 5.3.2 North America Nasopharyngeal Cancer Drug Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Nasopharyngeal Cancer Drug Import and Export
• 5.4 Europe Nasopharyngeal Cancer Drug Market Analysis
  • 5.4.1 Europe Nasopharyngeal Cancer Drug Production
  • 5.4.2 Europe Nasopharyngeal Cancer Drug Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Nasopharyngeal Cancer Drug Import and Export
• 5.5 China Nasopharyngeal Cancer Drug Market Analysis
  • 5.5.1 China Nasopharyngeal Cancer Drug Production
  • 5.5.2 China Nasopharyngeal Cancer Drug Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Nasopharyngeal Cancer Drug Import and Export
• 5.6 Japan Nasopharyngeal Cancer Drug Market Analysis
  • 5.6.1 Japan Nasopharyngeal Cancer Drug Production
  • 5.6.2 Japan Nasopharyngeal Cancer Drug Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Nasopharyngeal Cancer Drug Import and Export
• 5.7 Southeast Asia Nasopharyngeal Cancer Drug Market Analysis
  • 5.7.1 Southeast Asia Nasopharyngeal Cancer Drug Production
  • 5.7.2 Southeast Asia Nasopharyngeal Cancer Drug Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Nasopharyngeal Cancer Drug Import and Export
• 5.8 India Nasopharyngeal Cancer Drug Market Analysis
  • 5.8.1 India Nasopharyngeal Cancer Drug Production
  • 5.8.2 India Nasopharyngeal Cancer Drug Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Nasopharyngeal Cancer Drug Import and Export

6 Nasopharyngeal Cancer Drug Segment Market Analysis (by Type)

• 6.1 Global Nasopharyngeal Cancer Drug Production by Type
• 6.2 Global Nasopharyngeal Cancer Drug Revenue by Type
• 6.3 Nasopharyngeal Cancer Drug Price by Type

7 Nasopharyngeal Cancer Drug Segment Market Analysis (by Application)

• 7.1 Global Nasopharyngeal Cancer Drug Consumption by Application
• 7.2 Global Nasopharyngeal Cancer Drug Consumption Market Share by Application (2014-2019)

8 Nasopharyngeal Cancer Drug Major Manufacturers Analysis

• 8.1 Ambrx Inc
  • 8.1.1 Ambrx Inc Nasopharyngeal Cancer Drug Production Sites and Area Served
  • 8.1.2 Ambrx Inc Product Introduction, Application and Specification
  • 8.1.3 Ambrx Inc Nasopharyngeal Cancer Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 arGEN-X BV
  • 8.2.1 arGEN-X BV Nasopharyngeal Cancer Drug Production Sites and Area Served
  • 8.2.2 arGEN-X BV Product Introduction, Application and Specification
  • 8.2.3 arGEN-X BV Nasopharyngeal Cancer Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Atara Biotherapeutics Inc
  • 8.3.1 Atara Biotherapeutics Inc Nasopharyngeal Cancer Drug Production Sites and Area Served
  • 8.3.2 Atara Biotherapeutics Inc Product Introduction, Application and Specification
  • 8.3.3 Atara Biotherapeutics Inc Nasopharyngeal Cancer Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 AVEO Pharmaceuticals Inc
  • 8.4.1 AVEO Pharmaceuticals Inc Nasopharyngeal Cancer Drug Production Sites and Area Served
  • 8.4.2 AVEO Pharmaceuticals Inc Product Introduction, Application and Specification
  • 8.4.3 AVEO Pharmaceuticals Inc Nasopharyngeal Cancer Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 BeiGene Ltd
  • 8.5.1 BeiGene Ltd Nasopharyngeal Cancer Drug Production Sites and Area Served
  • 8.5.2 BeiGene Ltd Product Introduction, Application and Specification
  • 8.5.3 BeiGene Ltd Nasopharyngeal Cancer Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 BioDiem Ltd
  • 8.6.1 BioDiem Ltd Nasopharyngeal Cancer Drug Production Sites and Area Served
  • 8.6.2 BioDiem Ltd Product Introduction, Application and Specification
  • 8.6.3 BioDiem Ltd Nasopharyngeal Cancer Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 Biomics Biotechnologies Co Ltd
  • 8.7.1 Biomics Biotechnologies Co Ltd Nasopharyngeal Cancer Drug Production Sites and Area Served
  • 8.7.2 Biomics Biotechnologies Co Ltd Product Introduction, Application and Specification
  • 8.7.3 Biomics Biotechnologies Co Ltd Nasopharyngeal Cancer Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 Bristol-Myers Squibb Company
  • 8.8.1 Bristol-Myers Squibb Company Nasopharyngeal Cancer Drug Production Sites and Area Served
  • 8.8.2 Bristol-Myers Squibb Company Product Introduction, Application and Specification
  • 8.8.3 Bristol-Myers Squibb Company Nasopharyngeal Cancer Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 CBT Pharmaceuticals Inc
  • 8.9.1 CBT Pharmaceuticals Inc Nasopharyngeal Cancer Drug Production Sites and Area Served
  • 8.9.2 CBT Pharmaceuticals Inc Product Introduction, Application and Specification
  • 8.9.3 CBT Pharmaceuticals Inc Nasopharyngeal Cancer Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served
• 8.10 Celgene Corp
  • 8.10.1 Celgene Corp Nasopharyngeal Cancer Drug Production Sites and Area Served
  • 8.10.2 Celgene Corp Product Introduction, Application and Specification
  • 8.10.3 Celgene Corp Nasopharyngeal Cancer Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.10.4 Main Business and Markets Served
• 8.11 Cell Medica Ltd
• 8.12 F. Hoffmann-La Roche Ltd
• 8.13 GlaxoSmithKline Plc

9 Development Trend of Analysis of Nasopharyngeal Cancer Drug Market

• 9.1 Global Nasopharyngeal Cancer Drug Market Trend Analysis
  • 9.1.1 Global Nasopharyngeal Cancer Drug Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Nasopharyngeal Cancer Drug Regional Market Trend
  • 9.2.1 North America Nasopharyngeal Cancer Drug Forecast 2019-2025
  • 9.2.2 Europe Nasopharyngeal Cancer Drug Forecast 2019-2025
  • 9.2.3 China Nasopharyngeal Cancer Drug Forecast 2019-2025
  • 9.2.4 Japan Nasopharyngeal Cancer Drug Forecast 2019-2025
  • 9.2.5 Southeast Asia Nasopharyngeal Cancer Drug Forecast 2019-2025
  • 9.2.6 India Nasopharyngeal Cancer Drug Forecast 2019-2025
• 9.3 Nasopharyngeal Cancer Drug Market Trend (Product Type)
• 9.4 Nasopharyngeal Cancer Drug Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Nasopharyngeal Cancer Drug Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List